NCT01272258 · Interventional trial
A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence
Overall registry status Withdrawn
Phase 2
Conditions HIV
Delaware Valley sites
- Drexel University College of Medicine · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory